FOLH1 and metastatic neoplasm: However, these patients were assessed with conventional imaging methods (CT/MRI), and more recent evidence suggests that some may already have metastatic disease if prostate-specific membrane antigen ligand positron emission tomography (PSMA-PET) imaging had been employed instead.